Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2010
09/23/2010WO2010107068A1 METHOD FOR MEASURING β-GLUCAN, AND β-GLUCAN-BINDING PROTEIN FOR USE IN THE METHOD
09/23/2010WO2010106997A1 Method, kit and device for detecting nucleic acid
09/23/2010WO2010106989A1 Analysis chip, analysis method and method for stirring solution
09/23/2010WO2010106813A1 Method for imparting mating ability to yeast
09/23/2010WO2010106788A1 Fertility test method, fertility test kit, polynucleotide, polypeptide and antibody
09/23/2010WO2010106770A1 Neil3 peptides and vaccines including the same
09/23/2010WO2010106676A1 Method of increasing pigment amount in plant
09/23/2010WO2010106437A1 Peptides that inhibit angiotensin converting enzyme and peptides with antioxidant activity purified from ovotransferrin and methods of producing and using the same
09/23/2010WO2010106318A1 Screening plant glycosyltransferases for glycosylation of terpenoids in planta
09/23/2010WO2010106293A1 Analogs of temporin-sha, and uses thereof
09/23/2010WO2010106230A1 Manufacture of xylonic acid
09/23/2010WO2010106163A1 Nematode-resistant transgenic plants
09/23/2010WO2010105819A1 Tlr7 ligand and uses thereof
09/23/2010WO2010105573A1 Anti-angiogenic fusion proteins
09/23/2010WO2010105446A1 A human anti-tumor necrosis factor alpha monoclonal antibody and use thereof
09/23/2010WO2010105372A1 Compositions and methods for silencing hepatitis c virus expression
09/23/2010WO2010105311A1 Production of reprogrammed pluripotent cells
09/23/2010WO2010087888A3 Development of low allergen soybean seeds using molecular markers for the p34 allele
09/23/2010WO2010087805A9 Insult resistant plants and methods of producing and using the same
09/23/2010WO2010087564A3 Method for inducing improved dopaminergic neurons by mutant nurr1 gene expression
09/23/2010WO2010086512A3 Lactobacillus rhamnosus pilus polypeptides and methods for producing them
09/23/2010WO2010086189A3 Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
09/23/2010WO2010085295A3 Novel bacillus thuringiensis gene with lepidopteran activity
09/23/2010WO2010067969A3 Novel use of the loc284422 gene
09/23/2010WO2010066703A3 Desaturases and process for the production of polyunsaturated fatty acids in transgenic organisms
09/23/2010WO2010065735A3 Methods and compositions for treating p.acnes
09/23/2010WO2010060096A3 Compositions and methods for increasing cellulose production
09/23/2010WO2010057152A8 Cross-species chimeric rna molecules
09/23/2010WO2010056374A3 Methods and compositions of molecular profiling for disease diagnostics
09/23/2010WO2010054362A3 Temperature-induced polynucleotides and uses therefor
09/23/2010WO2010051204A4 Bcr-abl variants
09/23/2010WO2010031988A3 Polypeptides substrates of lrrk2 and uses thereof
09/23/2010WO2010026601A3 Vector for identification, selection and expression of recombinants
09/23/2010WO2009151600A3 Smad proteins control drosha-mediated mirna maturation
09/23/2010WO2009098690A8 Novel fer -like protein, pharmaceutical compositions containing it and method for its use
09/23/2010WO2001051665A9 Nanoparticles having oligonucleotides attached thereto and uses therefor
09/23/2010US20100242138 ODP1-2 Genes and Uses Thereof in Plants
09/23/2010US20100242137 Polynucleotides encoding proteins involved in plant metabolism
09/23/2010US20100242136 Udp-glucose modifiers
09/23/2010US20100242135 Etp1 and etp2 regulate plant ethylene response
09/23/2010US20100242134 Methods and polynucleotides for improving plants
09/23/2010US20100242132 Reversible Male Sterility in Transgenic Plants by Expression of Cytokinin Oxidase
09/23/2010US20100242130 Soybean variety d5247567
09/23/2010US20100242129 Soybean variety d5632454
09/23/2010US20100242125 Methods for correcting mitotic spindle defects and optimizing preimplantation embryonic developmental rates associated with somatic cell nuclear transfer in animals
09/23/2010US20100240881 Therapeutic compositions
09/23/2010US20100240876 Replikins and methods of identifying replikin-containing sequences
09/23/2010US20100240873 Ligand (act-4-l) to a receptor on the surface of activated cd4+ tcells
09/23/2010US20100240866 Modified gherlin peptides
09/23/2010US20100240740 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
09/23/2010US20100240738 Antisense modulation of kinesin-like 1 expression
09/23/2010US20100240737 Enzyme-prodrug therapy for prosthetic joint repair
09/23/2010US20100240736 Novel Compounds for the Treatment or Alleviation of Edema, and Methods for their Use
09/23/2010US20100240734 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
09/23/2010US20100240731 Lipopeptides for delivery of nucleic acids
09/23/2010US20100240687 Method for checking and controlling the mammalian lactic acid fermentation process/aerobic glucose fermentation metabolic pathway in mammalian organism
09/23/2010US20100240673 EML4-ALK Fusion Gene
09/23/2010US20100240590 Peptides and related molecules that bind to tall-1
09/23/2010US20100240584 Nematode-extracted serine protease inhibitors and anticoagulant proteins
09/23/2010US20100240583 Soluble protein and utilization of the same
09/23/2010US20100240575 Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same
09/23/2010US20100240554 siRNA Targeting Glucagon Receptor (GCGR)
09/23/2010US20100240547 Methods for selecting protein binding moieties
09/23/2010US20100240146 Fluorescent protein particles
09/23/2010US20100240145 Novel hemopoietin receptor protein, NR10
09/23/2010US20100240133 Compositions and Methods for Transposon Mutagenesis of Human Embryonic Stem Cells
09/23/2010US20100240132 Highly efficient methods for reprogramming differentiated cells and for generating animals and embryonic stem cells from reprogrammed cells
09/23/2010US20100240131 Method of modifying the genome of gram-positive bacteria by means of a novel conditionally negative dominant marker gene
09/23/2010US20100240125 Bone delivery conjugates and method of using same to target proteins to bone
09/23/2010US20100240100 Human antibodies that have mn binding and cell adhesion-neutralizing activity
09/23/2010US20100240098 Process for producing mature recombinant mite group i allergen
09/23/2010US20100240097 Mammalian expression vector with a highly efficient secretory signal sequence
09/23/2010US20100240096 Novel hemopoietin receptor protein, nr10
09/23/2010US20100240095 Polypeptides having cellobiohydrolase II activity and polynuleotides encoding same
09/23/2010US20100240084 Use of the protien maba (fabg1) of mycobacterium tuberculosis for designing and screening antibiotics
09/23/2010US20100240065 Prolyl Hydroxylase Compositions and Methods of Use Thereof
09/23/2010US20100240038 Method of screening a drug such as insulin secretagogue
09/23/2010US20100240029 Cholesterol-Regulating Complex of SIRT1 and LXR and Methods of Use
09/23/2010US20100239653 Pharmaceutical preparations and methods for inhibiting tumors
09/23/2010US20100239649 Tumor Suppressor Factor
09/23/2010US20100239613 Attenuated ehrlichiosis vaccine
09/23/2010US20100239608 PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS
09/23/2010US20100239594 Compositions and methods for production of immunoglobulins
09/23/2010US20100239591 Monoclonal antibody for app
09/23/2010US20100239588 The functional epitope of osteopontin, the anti-osteopontin monoclonal antibody and use thereof
09/23/2010US20100239584 Glycoconjugates and use thereof as vaccine against shigella flexneri serotype 3a and x
09/23/2010US20100239583 Antibodies against flagellin and uses thereof
09/23/2010US20100239582 Dual Specificity Antibody Fusions
09/23/2010US20100239579 CD47 Related Compositions and Methods for Treating Immunological Diseases and Disorders
09/23/2010US20100239575 Anti-cd40 antibodies and uses thereof
09/23/2010US20100239574 High potency recombinant antibodies and method for producing them
09/23/2010US20100239570 Moncolonal amyloid beta (abeta) - specific antibody and uses thereof
09/23/2010US20100239564 Novel human growth factors
09/23/2010US20100239563 Pharmaceutical composition for the prophylaxis and/or treatment of viral diseases
09/23/2010US20100239558 Lipid Hydrolysis Therapy for Atherosclerosis and Related Diseases
09/23/2010US20100239554 Extended recombinant polypeptides and compositions comprising same
09/23/2010US20100239548 Isolation and Identification of T Cells
09/23/2010US20100239546 Bacterial mediated tnf alpha gene silencing
09/23/2010US20100239543 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
09/23/2010US20100239542 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
1 ... 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 ... 4023